Clover Health Investments, Corp. (NASDAQ:CLOV) is one of Goldman Sachs’ top penny stock picks. On January 29, 2026, Clover Health Investments, Corp. (NASDAQ:CLOV) announced it will release ...

Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong ...

The average one-year price target for Clover Health Investments (NasdaqGS:CLOV) has been revised to $2.92 / share. This is a ...

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, ...

Clover Health also announced a significant increase in its Medicare Advantage membership. The membership rose to 153,000, marking a 53% increase during the Annual Enrollment Period. The company ...

WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, ...

WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial ...